TY  - GEN
AU  - Amor Aramendia, Aranzazu
AU  - Toro, Carlos
AU  - Fernandez-Martinez, Amalia
AU  - Baquero, Margarita
AU  - Benito, Agustin
AU  - Berzosa, Pedro
PY  - 2012
DO  - 10.1186/1475-2875-11-100
SN  - 1475-2875
UR  - http://hdl.handle.net/20.500.12105/6775
AB  - BACKGROUND: Drug resistance is a major problem to control Plasmodium falciparum infection in endemic countries. During last decade, African countries have changed first-line treatment to artemisinin-based combinations therapy (ACT);...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Africa
KW  - Alleles
KW  - Animals
KW  - Antimalarials
KW  - Artemisinins
KW  - DNA, Protozoan
KW  - Drug Combinations
KW  - Gene Frequency
KW  - Genotype
KW  - Humans
KW  - Malaria, Falciparum
KW  - Multidrug Resistance-Associated Proteins
KW  - Mutant Proteins
KW  - Mutation, Missense
KW  - Peptide Synthases
KW  - Plasmodium falciparum
KW  - Polymerase Chain Reaction
KW  - Polymorphism, Restriction Fragment Length
KW  - Pyrimethamine
KW  - Sulfadoxine
KW  - Tetrahydrofolate Dehydrogenase
KW  - Drug Resistance
KW  - Travel
TI  - Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy
TY  - research article
ER  -